|Day's Range||42.01 - 42.37|
|52 Week Range||33.38 - 43.95|
|PE Ratio (TTM)||33.64|
|Dividend & Yield||0.72 (1.71%)|
|1y Target Est||N/A|
Has embattled drugmaker Valeant Pharmaceuticals Intl Inc (NYSE:VRX) finally bottomed? Can VRX stock ever be trusted again? The market seems willing to bet that Valeant — which in the first quarter posted its first profit in six quarters and then raised guidance for 2017 — can not only sustain its operations but thrive.
Rating Action: Moody's affirms Nestlé's Aa2 rating; stable outlook. Global Credit Research- 28 Jun 2017. Milan, June 28, 2017-- Moody's Investors Service has today affirmed the Aa2 issuer rating of the ...
Schneider should listen to Loeb on this one.